Skip to main content

Table 2 EMBASE search strategy

From: Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol

Search steps

1. Imatinib Mesylate/

2. bexarotene.mp.

3. Busulfan/

4. Capecitabine/

5. Chlorambucil/

6. Cyclophosphamide/

7. Estramustine/

8. Etoposide/

9. Hydroxyurea/ or hydroxycarbamide.mp.

10. Melphalan/

11. mercaptopurine.mp. or 6-Mercaptopurine/

12. Lomustine/

13. Mitotane/

14. Procarbazine/

15. Tegafur/

16. temozolomide.mp.

17. Thioguanine/

18. Topotecan/

19. treosulfan.mp.

20. Tretinoin/

21. Trifluridine/

22. vinorelbine.mp.

23. afatinib.mp.

24. axitinib.mp.

25. bosutinib.mp.

26. cabozantinib.mp.

27. cobimetinib.mp.

28. crizotinib.mp.

29. ceritinib.mp.

30. dabrafenib.mp.

31. Dasatinib/

32. Erlotinib Hydrochloride/

33. Everolimus/

34. gefitinib.mp.

35. ibrutinib.mp.

36. idelalisib.mp.

37. lapatinib.mp.

38. nilotinib.mp.

39. nintedanib.mp.

40. olaparib.mp.

41. osimertinib.mp.

42. panobinostat.mp.

43. pazopanib.mp.

44. ponatinib.mp.

45. regorafenib.mp.

46. ruxolitinib.mp.

47. sorafenib.mp.

48. sunitinib.mp.

49. temsirolimus.mp.

50. trametinib.mp.

51. vandetanib.mp.

52. vemurafenib.mp.

53. vismodegib.mp.

54. Thalidomide/

55. lenalidomide.mp.

56. pomalidomide.mp.

57. anastrozole.mp.

58. exemestane.mp.

59. letrozole.mp.

60. Tamoxifen/

61. Toremifene/

62. Abiraterone Acetate/

63. bicalutamide.mp.

64. Cyproterone/ or Cyproterone Acetate/

65. enzalutamide.mp.

66. Flutamide/

67. Medroxyprogesterone/or Medroxyprogesterone Acetate/

68. Megestrol/or Megestrol Acetate/

69. norethisterone.mp. or Norethindrone/

70. Diethylstilbestrol/

71. Ethinyl Estradiol/or ethinylestradiol.mp.

72. Idarubicin/

73. Methotrexate/

74. Trifluridine/

75. lenvatinib.mp.

76. venetoclax.mp.

77. ixazomib.mp.

78. Palbociclib.mp.

79. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78

80. antineoplastic agent/ad [Drug Administration]

81. antineoplastic agent/dt [Drug Therapy]

82. antineoplastic agent/po [Oral Drug Administration]

83. antineoplastic agent/do [Drug Dose]

84. 80 or 81 or 82 or 83

85. (reduc* or attenuat* or discontinu* or modif* or dosing or schedul* or strateg* or dosage* or intercalat* or alternat* or personali* or break or holiday* or cessation or interrup* or intermit* or escala* or prescrib* or optimis* or optimiz* or tailor* or individuali* or "non conventional*" or nonconventional* or "non standard*" or nonstandard* or "treatment free").ab,ti.

86. (reduc* or attenuat* or discontinu* or modif* or dosing or schedul* or strateg* or dosage* or intercalat* or alternat* or personali* or break or holiday* or cessation or interrup* or intermit* or escala* or prescrib* or optimis* or optimiz* or tailor* or individuali* or "non conventional*" or nonconventional* or "non standard*" or nonstandard* or "treatment free").ti.

87. 79 and 84 and 85

88. 79 and 84 and 86